Overview
ELUT market data
Price History
ELUT price chart
Valuation & Profitability
- P/E (TTM)
- 0.75 Trailing twelve-month price-to-earnings ratio. Higher means the market is pricing in more growth. Negative or missing when earnings are negative.
- Forward P/E
- — P/E based on consensus forward EPS estimates. Lower versus trailing implies expected earnings growth.
- EPS (TTM)
- $1.29 Diluted earnings per share over the trailing twelve months.
- Beta
- 0.85 Volatility relative to the index. 1.00 equals market, above 1 amplifies the broad-market move, below 1 dampens it.
- Dividend Yield
- — Annual dividend per share divided by current price. Zero or blank when the company does not pay a dividend.
- Profit Margin
- 312.1% Net income divided by revenue. Comparable within a sector, less so across sectors.
- 52w range
- $0.50 – $2.50 Lowest and highest closing prices over the past 52 weeks.
- Analyst Target
- — Mean of sell-side analyst 12-month price targets. Use as a sentiment gauge; targets are biased upward in aggregate.
Display-only. Refreshed once per symbol per 24 hours · market cap $37.5M · P/B 1.07 · P/S 2.35.
Company News
Elutia Q2 2026 Earnings Call TranscriptBenzinga · Aug 13, 2026, 10:00 PM
Elutia Secures Up To $26M Of Additional Capital To Support NXT-41x Clearance And Its First Full Year Of Commercial Launch In 2028Benzinga · Aug 13, 2026, 8:33 PM
Elutia Q2 EPS $(0.17) Misses $(0.15) Estimate, Sales $2.427M Miss $2.900M EstimateBenzinga · Aug 13, 2026, 8:11 PM
8-K filing — ELUTIA INC. (ELUT)SEC EDGAR · Aug 7, 2026, 8:15 PM
Elutia Sheds Legacy Business to Chase $1.5 Billion Market OpportunityBenzinga · Jul 17, 2026, 4:07 PM
Elutia shares are trading higher after the company announced it signed a definitive agreement to sell its SimpliDerm business to Cellution Biologics.Benzinga · Jul 16, 2026, 8:07 PM
Elutia To Sell SimpliDerm Business To Cellution Biologics For Up To $11MBenzinga · Jul 16, 2026, 8:06 PM
Elutia Reports Q1 2026 Results: Full Earnings Call TranscriptBenzinga · May 14, 2026, 9:55 PM
Elutia Q1 EPS $(0.17) Misses $(0.15) Estimate, Sales $3.114M Beat $3.000M EstimateBenzinga · May 14, 2026, 8:14 PM